Skip to main content
Premium Trial:

Request an Annual Quote

VWR to Distribute Cepheid’s PCR-Based Detection/Analysis Products in US

NEW YORK (GenomeWeb News) — Cepheid said today VWR International will distribute its PCR-based detection technology in the US under a non-exclusive agreement.
 
Cepheid said the deal could expand its reach to more “government, academic and biotechnology laboratories” using PCR technology.
 
VWR will distribute Cepheid’s SmartCycler, which is used for genetic analysis and detection, and its SmartMix, which Cepheid said offers the reagents needed to perform PCR.
 
Financial terms of the agreement were not released.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.